Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Estey

Showing results (81-90 of 204) with videos related to

Pageof 21
Sort By:
Cancer Research|February 1, 1991
Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemiaS O'Brien, J A Benvenuto, E Estey, et al.
Investigational New Drugs|November 11, 1999
Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: results of a randomized phase I/II studyN Vey, H Kantarjian, M Beran, et al.
Drugs|January 1, 1994
Clinical experience with fludarabine in leukaemiaM J Keating, E Estey, S O'Brien, et al.
Cancer|December 12, 1997
Long-term follow-up of patients with newly diagnosed acute myeloid leukemia treated at the University of Texas M.D. Anderson Cancer CenterE Estey, M deLima, S Strom, et al.
Haematology and Blood Transfusion|January 1, 1990
Karyotype of leukemia cells consistently predicts for response to therapy and survival following salvage therapy in acute myeloblastic leukemiaM J Keating, H Kantarjian, E Estey, et al.
Biotechniques|May 18, 2001
Highly reproducible detection and semi-quantification of telomerase activityS Verstovsek, T Manshouri, H Kantarjian, et al.
Leukemia|October 26, 2002
More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemiaY O Huh, I Jilani, E Estey, et al.
Cancer|April 15, 1994
Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin BG P Bodey, E J Anaissie, L S Elting, et al.
Seminars in Hematology|July 1, 1990
Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defenseJ Gutterman, S Vadhan-Raj, C Logothetis, et al.
Leukemia & Lymphoma|November 9, 2001
High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndromeS Verstovsek, E Estey, T Manshouri, et al.
Pageof 21

Showing results (81-90 of 204) with videos related to

Sort By:
Pageof 21
Cancer Research|February 1, 1991
Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemiaS O'Brien, J A Benvenuto, E Estey, et al.
Investigational New Drugs|November 11, 1999
Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: results of a randomized phase I/II studyN Vey, H Kantarjian, M Beran, et al.
Drugs|January 1, 1994
Clinical experience with fludarabine in leukaemiaM J Keating, E Estey, S O'Brien, et al.
Cancer|December 12, 1997
Long-term follow-up of patients with newly diagnosed acute myeloid leukemia treated at the University of Texas M.D. Anderson Cancer CenterE Estey, M deLima, S Strom, et al.
Haematology and Blood Transfusion|January 1, 1990
Karyotype of leukemia cells consistently predicts for response to therapy and survival following salvage therapy in acute myeloblastic leukemiaM J Keating, H Kantarjian, E Estey, et al.
Biotechniques|May 18, 2001
Highly reproducible detection and semi-quantification of telomerase activityS Verstovsek, T Manshouri, H Kantarjian, et al.
Leukemia|October 26, 2002
More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemiaY O Huh, I Jilani, E Estey, et al.
Cancer|April 15, 1994
Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin BG P Bodey, E J Anaissie, L S Elting, et al.
Seminars in Hematology|July 1, 1990
Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defenseJ Gutterman, S Vadhan-Raj, C Logothetis, et al.
Leukemia & Lymphoma|November 9, 2001
High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndromeS Verstovsek, E Estey, T Manshouri, et al.
Pageof 21